Increasing evidences suggest that PI3K/AKT pathway plays an important role in the pathogenesis of inflammatory diseases such as
acute pancreatitis. However, the exact effect of PI3K/AKT on thyroid injury associated with
acute pancreatitis has not been investigated. This study aimed to investigate the protective effects of
wortmannin, PI3K/AKT inhibitor, on thyroid injury in a rat model of severe
acute pancreatitis (SAP). Sixty male SD rats were randomly divided into four groups:
sham operating group (SO), SAP group,
wortmannin treatment (WOR) group and drug control (WOR-CON) group. Serum
amylase (AMY),
lipase (LIP) and
thyroid hormone levels were evaluated. The morphological change of thyroid tissue was analyzed under the light and transmission electron microscopy. AKT, P38MAPK and NF-κB expression in the thyroid tissue was evaluated by immunohistochemical staining. Oxidative stress and inflammatory
cytokines were detected. Results showed that
wortmannin attenuated the following: (1) serum AMY, LIP and
thyroid hormone (2) pancreatic and thyroid pathological
injuries (3) thyroid MDA, (4) thyroid ultrastructural change, (5) serum TNF-α,
IL-6 and IL-1β (6) AKT, MAPKP38 and NF-κB expression in thyroid tissues. These results suggested that
wortmannin attenuates thyroid injury in SAP rats, presumably because of its role on prevent ROS generation and inhibits the activation of P38MAPK, NF-κB pathway. Our findings provide new therapeutic targets for thyroid injury associated with SAP.